Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 29

1.

Antidepressant actions of lateral habenula deep brain stimulation differentially correlate with CaMKII/GSK3/AMPK signaling locally and in the infralimbic cortex.

Kim Y, Morath B, Hu C, Byrne LK, Sutor SL, Frye MA, Tye SJ.

Behav Brain Res. 2016 Jun 1;306:170-7. doi: 10.1016/j.bbr.2016.02.039. Epub 2016 Mar 5.

PMID:
26956153
2.

Peripheral proinflammatory markers associated with ketamine response in a preclinical model of antidepressant-resistance.

Walker AJ, Foley BM, Sutor SL, McGillivray JA, Frye MA, Tye SJ.

Behav Brain Res. 2015 Oct 15;293:198-202. doi: 10.1016/j.bbr.2015.07.026. Epub 2015 Jul 21.

PMID:
26209292
3.

Generation and sequencing of pulmonary carcinoid tumor cell lines.

Asiedu MK, Thomas CF Jr, Tomaszek SC, Peikert T, Sanyal B, Sutor SL, Aubry MC, Li P, Wigle DA.

J Thorac Oncol. 2014 Dec;9(12):1763-71. doi: 10.1097/JTO.0000000000000339.

4.
5.

Role for putative hepatocellular carcinoma stem cell subpopulations in biological response to incomplete thermal ablation: in vitro and in vivo pilot study.

Thompson SM, Callstrom MR, Butters KA, Sutor SL, Knudsen B, Grande JP, Roberts LR, Woodrum DA.

Cardiovasc Intervent Radiol. 2014 Oct;37(5):1343-51. doi: 10.1007/s00270-013-0828-3. Epub 2014 Jan 23.

6.

A comparative genomic approach for identifying synthetic lethal interactions in human cancer.

Deshpande R, Asiedu MK, Klebig M, Sutor S, Kuzmin E, Nelson J, Piotrowski J, Shin SH, Yoshida M, Costanzo M, Boone C, Wigle DA, Myers CL.

Cancer Res. 2013 Oct 15;73(20):6128-36. doi: 10.1158/0008-5472.CAN-12-3956. Epub 2013 Aug 26.

7.

ATR inhibition broadly sensitizes ovarian cancer cells to chemotherapy independent of BRCA status.

Huntoon CJ, Flatten KS, Wahner Hendrickson AE, Huehls AM, Sutor SL, Kaufmann SH, Karnitz LM.

Cancer Res. 2013 Jun 15;73(12):3683-91. doi: 10.1158/0008-5472.CAN-13-0110. Epub 2013 Apr 2.

8.

Molecular bioluminescence imaging as a noninvasive tool for monitoring tumor growth and therapeutic response to MRI-guided laser ablation in a rat model of hepatocellular carcinoma.

Thompson SM, Callstrom MR, Knudsen BE, Anderson JL, Sutor SL, Butters KA, Kuo C, Grande JP, Roberts LR, Woodrum DA.

Invest Radiol. 2013 Jun;48(6):413-21. doi: 10.1097/RLI.0b013e31827a4a3f.

9.

MicroRNA-mRNA interactions in a murine model of hyperoxia-induced bronchopulmonary dysplasia.

Dong J, Carey WA, Abel S, Collura C, Jiang G, Tomaszek S, Sutor S, Roden AC, Asmann YW, Prakash YS, Wigle DA.

BMC Genomics. 2012 May 30;13:204. doi: 10.1186/1471-2164-13-204.

10.

c-Myc regulates self-renewal in bronchoalveolar stem cells.

Dong J, Sutor S, Jiang G, Cao Y, Asmann YW, Wigle DA.

PLoS One. 2011;6(8):e23707. doi: 10.1371/journal.pone.0023707. Epub 2011 Aug 17.

11.

Impact of fusion to Gα(i2) and co-expression with RGS proteins on pharmacological properties of human cannabinoid receptors CB₁R and CB₂R.

Sutor S, Heilmann J, Seifert R.

J Pharm Pharmacol. 2011 Aug;63(8):1043-55. doi: 10.1111/j.2042-7158.2011.01307.x. Epub 2011 Jun 8.

PMID:
21718288
12.

Severe osteogenesis imperfecta in cyclophilin B-deficient mice.

Choi JW, Sutor SL, Lindquist L, Evans GL, Madden BJ, Bergen HR 3rd, Hefferan TE, Yaszemski MJ, Bram RJ.

PLoS Genet. 2009 Dec;5(12):e1000750. doi: 10.1371/journal.pgen.1000750. Epub 2009 Dec 4.

13.

Renal upregulation of HO-1 reduces albumin-driven MCP-1 production: implications for chronic kidney disease.

Murali NS, Ackerman AW, Croatt AJ, Cheng J, Grande JP, Sutor SL, Bram RJ, Bren GD, Badley AD, Alam J, Nath KA.

Am J Physiol Renal Physiol. 2007 Feb;292(2):F837-44. Epub 2006 Sep 12.

14.

Selective activation of TACI by syndecan-2.

Bischof D, Elsawa SF, Mantchev G, Yoon J, Michels GE, Nilson A, Sutor SL, Platt JL, Ansell SM, von Bulow G, Bram RJ.

Blood. 2006 Apr 15;107(8):3235-42. Epub 2005 Dec 15.

15.

CAML is a p56Lck-interacting protein that is required for thymocyte development.

Tran DD, Edgar CE, Heckman KL, Sutor SL, Huntoon CJ, van Deursen J, McKean DL, Bram RJ.

Immunity. 2005 Aug;23(2):139-52.

16.

CAML is required for efficient EGF receptor recycling.

Tran DD, Russell HR, Sutor SL, van Deursen J, Bram RJ.

Dev Cell. 2003 Aug;5(2):245-56.

17.

Ischemic heart disease.

Sutor SM, Pennington JK, Cave DG.

Manag Care Interface. 2000 May;13(5):54-6. No abstract available.

PMID:
11067395
18.

Rheumatoid arthritis.

Sutor SM, Gricar JA, Cave DG.

Manag Care Interface. 1999 Jun;12(6):51-3. No abstract available.

PMID:
10538460
19.

Phosphorylation of Tyr319 in ZAP-70 is required for T-cell antigen receptor-dependent phospholipase C-gamma1 and Ras activation.

Williams BL, Irvin BJ, Sutor SL, Chini CC, Yacyshyn E, Bubeck Wardenburg J, Dalton M, Chan AC, Abraham RT.

EMBO J. 1999 Apr 1;18(7):1832-44.

20.

A phosphatidylinositol 3-kinase-dependent pathway that differentially regulates c-Raf and A-Raf.

Sutor SL, Vroman BT, Armstrong EA, Abraham RT, Karnitz LM.

J Biol Chem. 1999 Mar 12;274(11):7002-10.

Items per page

Supplemental Content

Write to the Help Desk